In 2023, the actual sales of anxiolytic medicines in Australia stood at 36 million US Dollars. Based on forecasted data, sales are expected to grow steadily from 2024 to 2028. The year-on-year growth rates are as follows: 1.6% from 2024 to 2025, 1.6% from 2025 to 2026, 1.6% from 2026 to 2027, and 1.6% from 2027 to 2028. The compound annual growth rate (CAGR) over the last five years, from 2023 to 2028, is 1.6%.
Future trends to watch for:
- Increasing awareness and diagnosis of anxiety disorders.
- Market penetration of new and advanced anxiolytic medications.
- The impact of mental health awareness campaigns on medication sales.
- Potential generic drug entries and their effect on market prices.
